Alimta (pemetrexed): Reviews and patient testimonials
Back to the list of medications
Medication indications
Alimta 100mg/500mg powder for concentrate for solution for infusion
Malignant pleural mesothelioma:
ALIMTA in combination with cisplatin is indicated for the treatment of chemotherapy naive patients with unresectable malignant pleural mesothelioma.
Non-small cell lung cancer:
ALIMTA in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) other than predominantly squamous cell histology.
ALIMTA is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.
ALIMTA is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.
Route of administration: Injectable
Molecule: pemetrexed
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.